Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
December 7, 2022 - 3 minutes
Multiple sclerosis
First of a kind multiple sclerosis biosimilar natalizumab accepted by US Food and Drug Association
Sandoz, a global pharmaceutical company working in generic and biosimilar medicines, announced this week that…
July 28, 2022 - 3 minutes
First-ever Marketing Authorization Application for biosimilar targeting MS filed
An international biotech, with headquarters in Amsterdam, has announced that the European Medicines Agency (EMA)…
July 18, 2022 - 3 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
Phase III Fail for MedDay’s Multiple Sclerosis Treatment
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
March 11, 2020 - 2 minutes
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis…
September 17, 2019 - 4 minutes
Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis
An antibody that blocks the action of a hidden viral protein encoded by our genome…
March 12, 2019 - 3 minutes
Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’
Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies…
December 19, 2018 - 3 minutes
New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech
Spanish biotech Bionure has started an early stage trial of a new drug to treat…
May 18, 2018 - 2 minutes
Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II
GeNeuro has released Phase IIb data showing that its antibody can reduce brain damage in…
March 26, 2018 - 2 minutes
Swiss Company Hits Another Slump with a Failed Multiple Sclerosis Trial
Just months after the EMA rejected its therapy for Duchenne muscular dystrophy, Swiss company Santhera…
March 5, 2018 - 2 minutes
Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies
Rewind Therapeutics has received a boost in the development of its multiple sclerosis therapies, raising a…
January 4, 2018 - 2 minutes
